| ISIN | IE00BSXNJK40 |
|---|---|
| Valor Number | 26529337 |
| Bloomberg Global ID | |
| Fund Name | Impax Global Equity Opportunities Class A |
| Fund Provider |
Impax Asset Management Limited
London, United Kingdom Phone: +44 20 7432 2609 E-Mail: info@impax.co.uk Web: www.impax.co.uk |
| Fund Provider | Impax Asset Management Limited |
| Representative in Switzerland |
CACEIS Bank, Montrouge, Zurich Branch / Switzerland Zurich Phone: +41 44 405 97 00 |
| Distributor(s) |
JP Morgan (Suisse) S.A. Genève Phone: +41 22 744 19 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Ireland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Fund’s investment objective is to generate long term capital growth through an actively managed portfolio of equities from issuers across global equity markets. |
| Peculiarities |
| Current Price * | 2.97 GBP | 28.11.2025 |
|---|---|---|
| Previous Price * | 2.96 GBP | 27.11.2025 |
| 52 Week High * | 3.12 GBP | 22.01.2025 |
| 52 Week Low * | 2.53 GBP | 07.04.2025 |
| NAV * | 2.97 GBP | 28.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 810,754,213 | |
| Unit/Share Assets *** | 1,757,244 | |
| Trading Information SIX | ||
| YTD Performance | +2.02% |
31.12.2024 - 28.11.2025
31.12.2024 28.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | -4.50% |
31.12.2024 - 28.11.2025
31.12.2024 28.11.2025 |
| 1 month | -3.94% |
28.10.2025 - 28.11.2025
28.10.2025 28.11.2025 |
| 3 months | -0.37% |
28.08.2025 - 28.11.2025
28.08.2025 28.11.2025 |
| 6 months | +4.98% |
28.05.2025 - 28.11.2025
28.05.2025 28.11.2025 |
| 1 year | -1.26% |
28.11.2024 - 28.11.2025
28.11.2024 28.11.2025 |
| 2 years | +16.13% |
28.11.2023 - 28.11.2025
28.11.2023 28.11.2025 |
| 3 years | +18.91% |
28.11.2022 - 28.11.2025
28.11.2022 28.11.2025 |
| 5 years | +36.86% |
30.11.2020 - 28.11.2025
30.11.2020 28.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Microsoft Corp | 5.69% | |
|---|---|---|
| NVIDIA Corp | 5.00% | |
| Boston Scientific Corp | 4.10% | |
| Linde PLC | 3.42% | |
| Mastercard Inc Class A | 3.35% | |
| KBC Groupe NV | 2.98% | |
| Intuitive Surgical Inc | 2.97% | |
| Xylem Inc | 2.96% | |
| Oracle Corp | 2.80% | |
| Hubbell Inc | 2.77% | |
| Last data update | 31.10.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | 1.07% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |